Healthcare & Life Sciences

Sab Biotherapeutics

Sign in to unlock

About

Develops a platform for fully-human antibody therapies aimed at treating autoimmune and infectious diseases by improving safety and pharmacological properties.

Explore Sab Biotherapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing